<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05096104</url>
  </required_header>
  <id_info>
    <org_study_id>8294</org_study_id>
    <nct_id>NCT05096104</nct_id>
  </id_info>
  <brief_title>Patient Satisfaction During Artificial Induction of Labor by Cervical Ripening</brief_title>
  <acronym>CERVICAL</acronym>
  <official_title>Patient Satisfaction During Artificial Induction of Labor by Cervical Ripening</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Strasbourg, France</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Strasbourg, France</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      20% of deliveries take place following an artificial induction of labor. The latter sometimes&#xD;
      requires prior cervical ripening, of which the two most widely used methods in France are&#xD;
      oral misoprostol and the balloon catheter, left to the discretion of clinicians.&#xD;
&#xD;
      The objective of this study is to observe which cervical maturation method patients choose&#xD;
      when an artificial induction of labor with an unfavorable cervical status must be carried&#xD;
      out, and to observe the patient's criteria as to the choice made, as well as their experience&#xD;
      and their satisfaction with artificial induction of labor, in order to improve our clinical&#xD;
      practices, the experience of childbirth, and promote patient autonomy.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">August 6, 2021</start_date>
  <completion_date type="Anticipated">October 6, 2022</completion_date>
  <primary_completion_date type="Anticipated">October 6, 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Retrospective study of the cervical ripening method that patients choose when artificial induction of labor with unfavorable cervical status must be performed</measure>
    <time_frame>Files analysed retrospectively from JFebruary 01, 2020 to February 29, 2021 will be examined]</time_frame>
  </primary_outcome>
  <enrollment type="Anticipated">800</enrollment>
  <condition>Cervical Ripening</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Adult woman who underwent induction of labor between February 1, 2020 and February 29, 2021&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Adult woman (≥18 years old)&#xD;
&#xD;
          -  Patient who underwent induction of labor between February 1, 2020 and February 29,&#xD;
             2021&#xD;
&#xD;
          -  Patient not having expressed her opposition, after information, to the reuse of her&#xD;
             data for the purposes of this research.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patient who expressed her opposition to participating in the study&#xD;
&#xD;
          -  Absence of prior cervical maturation (Bishop score greater than or equal to 6 on the&#xD;
             day of initiation)&#xD;
&#xD;
          -  Gestational age less than 37 weeks, multiple pregnancy, scarred uterus, non-cephalic&#xD;
             presentation, death in utero and severe fetal malformation (requiring neonatal&#xD;
             resuscitation or with a palliative care plan)&#xD;
&#xD;
          -  Patient for whom the triggering method was chosen by the practitioner&#xD;
&#xD;
          -  Patient under guardianship, curatorship or safeguard of justice&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
  </eligibility>
  <overall_official>
    <last_name>Nicolas SANANES, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Service de gynécologie Obstétrique - Hôpitaux Universitaires de Strasbourg</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Nicolas SANANES, MD, PhD</last_name>
    <phone>33 3 69 55 33 97</phone>
    <email>nicolas.sananes@chru-strasbourg.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Saïd CHAYER, PhD, HDR</last_name>
    <phone>33 3 88 11 66 90</phone>
    <email>said.chayer@chru-strasbourg.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Service de gynécologie Obstétrique - Hôpitaux Universitaires de Strasbourg</name>
      <address>
        <city>Strasbourg</city>
        <zip>67091</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nicolas SANANES, MD, PhD</last_name>
      <phone>33.3.69.55.33.97</phone>
      <email>nicolas.sananes@chru-strasbourg.fr</email>
    </contact>
    <contact_backup>
      <last_name>Saïd CHAYER, PhD, HDR</last_name>
      <phone>33 3 88 11 66 90</phone>
      <email>said.chayer@chru-strasbourg.fr</email>
    </contact_backup>
    <investigator>
      <last_name>Nicolas SANANES, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Emeline FLAMENT, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>August 2021</verification_date>
  <study_first_submitted>August 6, 2021</study_first_submitted>
  <study_first_submitted_qc>October 14, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">October 27, 2021</study_first_posted>
  <last_update_submitted>October 14, 2021</last_update_submitted>
  <last_update_submitted_qc>October 14, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 27, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Cervical Ripening</keyword>
  <keyword>PREGNANCY</keyword>
  <keyword>LABOR INDUCED</keyword>
  <keyword>Artificial induction</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

